Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Letter
  • Published:

Anti-inflammatory activity of IgG1 mediated by Fc galactosylation and association of FcγRIIB and dectin-1

Abstract

Complement is an ancient danger-sensing system that contributes to host defense, immune surveillance and homeostasis1. C5a and its G protein–coupled receptor mediate many of the proinflammatory properties of complement2. Despite the key role of C5a in allergic asthma3, autoimmune arthritis4, sepsis5 and cancer6, knowledge about its regulation is limited. Here we demonstrate that IgG1 immune complexes (ICs), the inhibitory IgG receptor FcγRIIB and the C-type lectin–like receptor dectin-1 suppress C5a receptor (C5aR) functions. IgG1 ICs promote the association of FcγRIIB with dectin-1, resulting in phosphorylation of Src homology 2 domain–containing inositol phosphatase (SHIP) downstream of FcγRIIB and spleen tyrosine kinase downstream of dectin-1. This pathway blocks C5aR-mediated ERK1/2 phosphorylation, C5a effector functions in vitro and C5a-dependent inflammatory responses in vivo, including peritonitis and skin blisters in experimental epidermolysis bullosa acquisita. Notably, high galactosylation of IgG N-glycans is crucial for this inhibitory property of IgG1 ICs, as it promotes the association between FcγRIIB and dectin-1. Thus, galactosylated IgG1 and FcγRIIB exert anti-inflammatory properties beyond their impact on activating FcγRs.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: IgG1-ICs inhibit C5a-mediated inflammatory responses in vivo and in vitro by an FcγRIIB-dependent mechanism.
Figure 2: The inhibitory effect of IgG1-ICs on neutrophil migration depends on dectin-1.
Figure 3: IgG1-ICs activate Src kinase and promote phosphorylation of tyrosine and Syk downstream of dectin-1 and of SHIP downstream of FcγRIIB.
Figure 4: High Fc glycan galactosylation is crucial for the inhibitory effect of IgG1-ICs in vivo and promotes the association of FcγRIIB and dectin-1.

Similar content being viewed by others

References

  1. Ricklin, D., Hajishengallis, G., Yang, K. & Lambris, J.D. Complement: a key system for immune surveillance and homeostasis. Nat. Immunol. 11, 785–797 (2010).

    Article  CAS  Google Scholar 

  2. Klos, A. et al. The role of the anaphylatoxins in health and disease. Mol. Immunol. 46, 2753–2766 (2009).

    Article  CAS  Google Scholar 

  3. Köhl, J. et al. A regulatory role for the C5a anaphylatoxin in type 2 immunity in asthma. J. Clin. Invest. 116, 783–796 (2006).

    Article  Google Scholar 

  4. Hashimoto, M. et al. Complement drives TH17 cell differentiation and triggers autoimmune arthritis. J. Exp. Med. 207, 1135–1143 (2010).

    Article  CAS  Google Scholar 

  5. Rittirsch, D. et al. Functional roles for C5a receptors in sepsis. Nat. Med. 14, 551–557 (2008).

    Article  CAS  Google Scholar 

  6. Markiewski, M.M. et al. Modulation of the antitumor immune response by complement. Nat. Immunol. 9, 1225–1235 (2008).

    Article  CAS  Google Scholar 

  7. Clynes, R., Dumitru, C. & Ravetch, J.V. Uncoupling of immune complex formation and kidney damage in autoimmune glomerulonephritis. Science 279, 1052–1054 (1998).

    Article  CAS  Google Scholar 

  8. Wenderfer, S.E. et al. C5a receptor deficiency attenuates T cell function and renal disease in MRLlpr mice. J. Am. Soc. Nephrol. 16, 3572–3582 (2005).

    Article  CAS  Google Scholar 

  9. Ji, H. et al. Arthritis critically dependent on innate immune system players. Immunity 16, 157–168 (2002).

    Article  CAS  Google Scholar 

  10. Shushakova, N. et al. C5a anaphylatoxin is a major regulator of activating versus inhibitory FcγRs in immune complex–induced lung disease. J. Clin. Invest. 110, 1823–1830 (2002).

    Article  CAS  Google Scholar 

  11. Godau, J. et al. C5a initiates the inflammatory cascade in immune complex peritonitis. J. Immunol. 173, 3437–3445 (2004).

    Article  CAS  Google Scholar 

  12. Nimmerjahn, F. & Ravetch, J.V. Fcγ receptors as regulators of immune responses. Nat. Rev. Immunol. 8, 34–47 (2008).

    Article  CAS  Google Scholar 

  13. Strait, R.T., Morris, S.C. & Finkelman, F.D. IgG-blocking antibodies inhibit IgE-mediated anaphylaxis in vivo through both antigen interception and FcγRIIb cross-linking. J. Clin. Invest. 116, 833–841 (2006).

    Article  CAS  Google Scholar 

  14. Jones, S.L., Knaus, U.G., Bokoch, G.M. & Brown, E.J. Two signaling mechanisms for activation of αMβ2 avidity in polymorphonuclear neutrophils. J. Biol. Chem. 273, 10556–10566 (1998).

    Article  CAS  Google Scholar 

  15. Otto, M. et al. C5a mutants are potent antagonists of the C5a receptor (CD88) and of C5L2: position 69 is the locus that determines agonism or antagonism. J. Biol. Chem. 279, 142–151 (2004).

    Article  CAS  Google Scholar 

  16. Taylor, P.R. et al. The β-glucan receptor, dectin-1, is predominantly expressed on the surface of cells of the monocyte/macrophage and neutrophil lineages. J. Immunol. 169, 3876–3882 (2002).

    Article  CAS  Google Scholar 

  17. Goodridge, H.S. et al. Activation of the innate immune receptor dectin-1 upon formation of a 'phagocytic synapse'. Nature 472, 471–475 (2011).

    Article  CAS  Google Scholar 

  18. Taylor, P.R. et al. Dectin-1 is required for β-glucan recognition and control of fungal infection. Nat. Immunol. 8, 31–38 (2007).

    Article  CAS  Google Scholar 

  19. McDonald, J.U. et al. In vivo functional analysis and genetic modification of in vitro–derived mouse neutrophils. FASEB J. 25, 1972–1982 (2011).

    Article  CAS  Google Scholar 

  20. Rogers, N.C. et al. Syk-dependent cytokine induction by dectin-1 reveals a novel pattern recognition pathway for C type lectins. Immunity 22, 507–517 (2005).

    Article  CAS  Google Scholar 

  21. Wex, E. et al. Induced Syk deletion leads to suppressed allergic responses but has no effect on neutrophil or monocyte migration in vivo. Eur. J. Immunol. 41, 3208–3218 (2011).

    Article  CAS  Google Scholar 

  22. Dennehy, K.M., Klimosch, S.N. & Steinle, A. Cutting edge: NKp80 uses an atypical hemi-ITAM to trigger NK cytotoxicity. J. Immunol. 186, 657–661 (2011).

    Article  CAS  Google Scholar 

  23. Nimmerjahn, F. & Ravetch, J.V. Divergent immunoglobulin g subclass activity through selective Fc receptor binding. Science 310, 1510–1512 (2005).

    Article  CAS  Google Scholar 

  24. Malhotra, R. et al. Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein. Nat. Med. 1, 237–243 (1995).

    Article  CAS  Google Scholar 

  25. Raju, T.S. Terminal sugars of Fc glycans influence antibody effector functions of IgGs. Curr. Opin. Immunol. 20, 471–478 (2008).

    Article  CAS  Google Scholar 

  26. Geijtenbeek, T.B. & Gringhuis, S.I. Signalling through C-type lectin receptors: shaping immune responses. Nat. Rev. Immunol. 9, 465–479 (2009).

    Article  CAS  Google Scholar 

  27. Barb, A.W. & Prestegard, J.H. NMR analysis demonstrates immunoglobulin G N-glycans are accessible and dynamic. Nat. Chem. Biol. 7, 147–153 (2011).

    Article  CAS  Google Scholar 

  28. Wernersson, S. et al. IgG-mediated enhancement of antibody responses is low in Fc receptor γ chain–deficient mice and increased in Fc γ RII–deficient mice. J. Immunol. 163, 618–622 (1999).

    CAS  Google Scholar 

  29. Sitaru, C. et al. Induction of dermal-epidermal separation in mice by passive transfer of antibodies specific to type VII collagen. J. Clin. Invest. 115, 870–878 (2005).

    Article  CAS  Google Scholar 

  30. Yoshitomi, H. et al. A role for fungal β-glucans and their receptor dectin-1 in the induction of autoimmune arthritis in genetically susceptible mice. J. Exp. Med. 201, 949–960 (2005).

    Article  CAS  Google Scholar 

  31. Manicassamy, S. et al. Toll-like receptor 2–dependent induction of vitamin A–metabolizing enzymes in dendritic cells promotes T regulatory responses and inhibits autoimmunity. Nat. Med. 15, 401–409 (2009).

    Article  CAS  Google Scholar 

  32. Anthony, R.M., Wermeling, F., Karlsson, M.C. & Ravetch, J.V. Identification of a receptor required for the anti-inflammatory activity of IVIG. Proc. Natl. Acad. Sci. USA 105, 19571–19578 (2008).

    Article  CAS  Google Scholar 

  33. Arnold, J.N., Wormald, M.R., Sim, R.B., Rudd, P.M. & Dwek, R.A. The impact of glycosylation on the biological function and structure of human immunoglobulins. Annu. Rev. Immunol. 25, 21–50 (2007).

    Article  CAS  Google Scholar 

  34. Agarwal, S. & Cunningham-Rundles, C. Autoimmunity in common variable immunodeficiency. Curr. Allergy Asthma Rep. 9, 347–352 (2009).

    Article  CAS  Google Scholar 

  35. Nimmerjahn, F. & Ravetch, J.V. Analyzing antibody-Fc-receptor interactions. Methods Mol. Biol. 415, 151–162 (2008).

    CAS  Google Scholar 

  36. Graham, I.L., Anderson, D.C., Holers, V.M. & Brown, E.J. Complement receptor 3 (CR3, Mac-1, integrin alpha M beta 2, CD11b/CD18) is required for tyrosine phosphorylation of paxillin in adherent and nonadherent neutrophils. J. Cell Biol. 127, 1139–1147 (1994).

    Article  CAS  Google Scholar 

  37. Wang, G.G. et al. Quantitative production of macrophages or neutrophils ex vivo using conditional Hoxb8. Nat. Methods 3, 287–293 (2006).

    Article  CAS  Google Scholar 

  38. Rosas, M. et al. The induction of inflammation by dectin-1 in vivo is dependent on myeloid cell programming and the progression of phagocytosis. J. Immunol. 181, 3549–3557 (2008).

    Article  CAS  Google Scholar 

  39. Wedepohl, S. et al. N-glycan analysis of recombinant L-selectin reveals sulfated GalNAc and GalNAc-GalNAc motifs. J. Proteome Res. 9, 3403–3411 (2010).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work is supported by the German Research Foundation (Deutsche Forschungsgemeinschaft, GRK1727; project 8 and SFB/TR22; project A21) to J.K., EXC306/1 to D.Z., R.L. and J.K., and by Deutsche Forschungsgemeinschaft EH221-5 to M.E. P.R.T. is a Medical Research Council (UK) Senior Fellow (G0601617). G.D.B. was supported by the Wellcome Trust. We thank T. Köhli for technical assistance with the surface plasmon resonance analysis, T. Gutsmann for help with the fluorescence spectroscopy measurements, T. Peters and L. Wollin for helpful discussions and B. Heyman (Uppsala University, Sweden) for providing the H5 and the 7B4 hybridoma clones.

Author information

Authors and Affiliations

Authors

Contributions

C.M.K. and M.K.P. conducted key studies and analyzed the data. J.F. assessed antigen binding of in vitro–glycosylated IgGs and performed phenotypical characterization of bone marrow cells, and some in vivo studies. R.K. and C.M.K. performed the EBA studies. R.L. and D.Z. provided the rabbit collagen type VII–specific IgG for the EBA studies and helped with EBA-related data analysis. P.R.T., M.R. and J.U.M. provided the dectin-1–transduced neutrophil and macrophage cell lines, and helped with assays using such lines. S.J.O. performed the peptide pull-down experiments. M.B., D.P. and V.B. did the MALDI-TOF analysis. A.W. and C.H. performed the in vitro galactosylation of the H5 antibody. G.D.B. and D.M.R. provided the Clec7a−/− mice and helped with the neutrophil assays using such mice and with ex vivo assays with primary Clec7a−/− cells. I.V.M. provided material and advice for the FRET experiments. R.T.S. and F.D.F. provided TNP-OVA and helped with initial IC studies. N.L.H. and G.K. performed the ERK phosphorylation studies with neutrophils. E.W. provided the conditional Syk-knockout mice and the protocol for in vitro Syk depletion. F.N. provided the recombinant IgG1 7B4 antibody and recombinant mouse FcγRIIB-Fc and assessed HiGalH5-IC and H5-IC binding to FcγRIIB-transfected Chinese hamster ovary cells. M.E. provided scientific input and coordinated the glycan analysis. J.K. designed and coordinated the study, analyzed the data and wrote the manuscript.

Corresponding author

Correspondence to Jörg Köhl.

Ethics declarations

Competing interests

E.W. is an employee of Boehringer Ingelheim Pharma.

Supplementary information

Supplementary Text and Figures

Supplementary Figures 1–23 and Supplementary Table 1 (PDF 4835 kb)

Supplementary Movie 1

Expression of FcγRIIB but absence of Syk phosphorylation in untreated BM neutrophils. This movie shows the expression pattern of FcγRIIB (green, anti-FcγRIIB-FITC Ab) and of phosphorylated Syk (p-Syk, magenta, anti–p-Syk–Alexa568 Ab) in a BM-derived neutrophil 3 min after incubation with PBS, as determined by confocal microscopy in an animated three-dimensional projection. Cell stains positive for FcγRIIB. No phosphorylation of Syk is visible in the absence of 107.3-IC treatment. Similar results were obtained for p-SHIP. (MOV 1966 kb)

Supplementary Movie 2

Expression of dectin-1 but absence of Syk phosphorylation in untreated BM neutrophils. This movie shows the expression pattern of dectin-1 (magenta, anti–dectin-1–APC Ab) and phosphorylated Syk (p-Syk, green, anti–-p-Syk–Alexa568 Ab) in a BM-derived neutrophil 3 min after incubation with PBS, as determined by confocal microscopy in an animated three-dimensional projection. No phosphorylation of Syk occurs in the absence of 107.3-IC treatment. Similar results were obtained for p-SHIP. (MOV 1340 kb)

Supplementary Movie 3

Phosphorylation of Syk and co-localization of p-Syk with FcγRIIB in response to 107.3-IC treatment. This movie shows the co-localization pattern of FcγRIIB (green, anti-FcγRIIB-FITC Ab) and of phosphorylated Syk (p-Syk, magenta, anti-p-Syk-Alexa568 Ab) in a BM-derived neutrophil 3 min following 107.3-IC treatment, as determined by confocal microscopy in an animated three-dimensional projection. 107.3-IC treatment drives phosphorylation of Syk; p-Syk co-localizes with FcγRIIB as indicated by the white spots. Similar results were obtained for p-SHIP. (MOV 2750 kb)

Supplementary Movie 4

Phosphorylation of Syk and co-localization of p-Syk with dectin-1 in response to 107.3-IC treatment. This movie shows the co-localization pattern of dectin-1 (magenta, anti–dectin-1–APC Ab) and phosphorylated Syk (p-Syk, green, anti-p-Syk-Alexa568 Ab) in a BM-derived neutrophil 3 min following 107.3-IC treatment, as determined by confocal microscopy in an animated three-dimensional projection. 107.3-IC treatment drives phosphorylation of Syk; p-Syk co-localizes with dectin-1 as indicated by the white spots. Similar results were obtained for p-SHIP. (MOV 1771 kb)

Supplementary Movie 5

107.3-IC treatment promotes association of FcγRIIB and dectin-1. This movie shows the co-localization pattern of FcγRIIB (green, anti-FcγRIIB-FITC Ab) and of dectin-1 (magenta, anti–dectin-1–APC Ab) in a BM-derived neutrophil 3 min after incubation with IgG1 IC, as determined by confocal microscopy in an animated three-dimensional projection. Co-localization of FcγRIIB and dectin-1 is indicated by the white spots. (MOV 1271 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Karsten, C., Pandey, M., Figge, J. et al. Anti-inflammatory activity of IgG1 mediated by Fc galactosylation and association of FcγRIIB and dectin-1. Nat Med 18, 1401–1406 (2012). https://doi.org/10.1038/nm.2862

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nm.2862

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing